Molecular Classification
Extracellular aggregate, Protein aggregate
Other Names
Amyloid plaques, Neuritic plaques, Senile plaques
Disease Roles
Alzheimer's diseaseNeurodegenerative disease

Beta Amyloid Plaque Overview

Beta amyloid plaques are extracellular deposits primarily composed of aggregated amyloid beta (Aβ) protein. These structures are most commonly found in the grey matter of the brain and are a defining pathological feature of Alzheimer's disease. While some plaque formation can occur with normal aging, their abundance and association with neurofibrillary tangles distinguish Alzheimer’s pathology.

Mechanism of Action

Biological Functions

No known physiological function when aggregated
Induction of synaptic loss
Induction of neuronal death
Activation of microglia and astrocytes
Induction of local inflammation

Disease Associations

Alzheimer's disease
Neurodegenerative disease

Safety Considerations

  • Therapeutic targeting has had limited clinical success
  • Synaptic dysfunction begins before large-scale aggregation occurs
  • Off-target effects of anti-amyloid therapies

Associated Biomarkers

Biomarker
Plaque density (post-mortem)
Amyloid beta levels in cerebrospinal fluid
Amyloid PET imaging